Israeli HMO adopts ACR imaging criteria

Article

Maccabi Health Care Services, the second largest HMO in Israel, saw utilization of CT and MR decrease after it implemented American College of Radiology appropriateness criteria in 2002.

Maccabi Health Care Services, the second largest HMO in Israel, saw utilization of CT and MR decrease after it implemented American College of Radiology appropriateness criteria in 2002.

CT use dropped 33% and MR use fell 8.7% in the 23 months after preauthorization requirements were instituted for the two modalities, Dr. Arve Blacher said at the 2004 RSNA meeting. Costs associated with the two procedures represented 1.4% of the provider's healthcare budget.

Referring physicians must phone in MR and CT requests to a central site for authorization. The call center staff responds with either an immediate authorization or a deferral followed by a written explanation.

A phone discussion with a radiologist to explain the decision is available on demand. In disputed cases, the referring physician may still order CT, but MR imaging may not be performed until after the disposition of an appeal.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.